Gemcitabine Plus Nab-Paclitaxel as Second-Line Chemotherapy following FOLFIRINOX in Patients with Unresectable Pancreatic Cancer: A Single-Institution, Retrospective Analysis
Conclusions: GnP after FOLFIRINOX is expected to be one of the second-line recommendations for patients with unresectable pancreatic cancer.Chemotherapy
Source: Chemotherapy - Category: Cancer & Oncology Source Type: research
More News: Anemia | Cancer | Cancer & Oncology | Chemotherapy | Pancreas | Pancreatic Cancer | Study